Homeopathic Claims Have FTC Searching For Remedy To Regulatory Conflict With FDA

15 Dec 2014

FTC shuts down the second marketer this year for making fraudulent claims for human chorionic gonadotropin weight-loss products. Enforcing against other homeopathics’ claims that violate advertising regulations, however, is on hold until FTC resolves its differences with FDA’s regulatory oversight of the products.

Federal Trade Commission enforcement against human chorionic gonadotropin weight-loss products is the tip of the iceberg in the agency’s concerns about homeopathic product claims, questions that sometimes conflict with FDA’s oversight of the products.

FTC on Dec. 11 said Utah businessman Kevin Wright agreed to pay $1 million to settle charges that weight loss...